In Helicobacter pylori infection, activation of the cGMP/PKG signaling pathway leads to the occurrence and development of gastric cancer, while blocking the PRTG/cGMP/PKG axis holds potential for gastric cancer treatment [19]. This evidence concerns the gene PRTG and gastric cancer.